Search Within

Kai Dannebom Rejeski

Formats
  1. Journal Article (14)
  2. Meeting Abstract (11)
  3. Review (7)
  4. Editorial (2)
  5. Research Letter (1)
Groups
  1. Hematologic Malignancies, Division of (22)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Bone Marrow Transplant (15)
  5. GME, Medicine (15)
  6. Graduate Medical Education (15)

More Groups

People
  1. Roni Shouval (20)
  2. Miguel-Angel Perales (15)
  3. Gilles Salles (11)
  4. Jae Park (11)
  5. Maria Palomba (10)
  6. Gunjan Shah (9)

More People

Years
  1. 2025 (15)
  2. 2024 (20)
Publications
  1. Blood (11)
  2. Blood Advances (3)
  3. Bone Marrow Transplantation (3)
  4. Blood Cancer Journal (2)
  5. HemaSphere (2)
  6. Nature Medicine (2)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Nature Publishing Group (8)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (2)
  5. Elsevier Science, Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment
    Journal Article

    Pelzl, R. J.; Benintende, G.; Gsottberger, F.; Scholz, J. K.; Rübner, M.; Yao, H.; Wendland, K.; Rejeski, K.; Altmann, H.; Petkovic, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Noncanonical and mortality-defining toxicities of CAR T cell therapy
    Review

    Rejeski, K.; Hill, J. A.; Dahiya, S.; Jain, M. D.
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Off-the-shelf iPSC natural killer-cell therapy: A new chapter for B-cell lymphoma?
    Editorial

    Tix, T.; Rejeski, K.
    The Lancet Haematology (2025)

    Fulltext@MSK | Save
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma
    Review

    Tix, T.; Alhomoud, M.; Shouval, R.; Iacoboni, G.; Cliff, E. R. S.; Hansen, D. K.; Usmani, S. Z.; Salles, G.; Perales, M. A.; Cordas dos Santos, D. M.; more...
    Molecular Therapy (2025)

    Fulltext@MSK | Save
  • Immune effector cell-associated hematotoxicity: Mechanisms, clinical manifestations, and management strategies
    Review

    Beyar-Katz, O.; Rejeski, K.; Shouval, R.
    Haematologica (2025)

    Fulltext@MSK | Save
  • Survivorship in chimeric antigen receptor T-cell therapy recipients: Infections, secondary malignancies, and non-relapse mortality
    Review

    Tix, T.; Subklewe, M.; Von Bergwelt-Baildon, M.; Rejeski, K.
    Oncology Research and Treatment (2025)

    Fulltext@MSK | Save
  • Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
    Journal Article

    Corona, M.; Ip, A.; Brown, S.; Luna, A.; Khatib, H.; Flynn, J. R.; Devlin, S. M.; Landego, I.; Cassanello, G.; Rejeski, K.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
    Journal Article

    Luna, A.; Devlin, S. M.; Rejeski, K.; Flynn, J. R.; Corona, M.; Luttwak, E.; Rivas-Delgado, A.; Landego, I.; Cassanello, G.; Gomez-Llobell, M.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save